Growth Metrics

ProPhase Labs (PRPH) Net Income towards Common Stockholders: 2010-2025

Historic Net Income towards Common Stockholders for ProPhase Labs (PRPH) over the last 16 years, with Sep 2025 value amounting to -$6.8 million.

  • ProPhase Labs' Net Income towards Common Stockholders fell 321.64% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year increase of 70.61%. This contributed to the annual value of -$3.8 million for FY2024, which is 854.98% down from last year.
  • ProPhase Labs' Net Income towards Common Stockholders amounted to -$6.8 million in Q3 2025, which was down 52.93% from -$4.5 million recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Net Income towards Common Stockholders ranged from a high of $12.7 million in Q1 2022 and a low of -$8.3 million during Q4 2023.
  • In the last 3 years, ProPhase Labs' Net Income towards Common Stockholders had a median value of -$1.6 million in 2024 and averaged -$2.1 million.
  • Over the last 5 years, ProPhase Labs' Net Income towards Common Stockholders had its largest YoY gain of 28,422.50% in 2021, and its largest YoY loss of 2,570.81% in 2021.
  • Over the past 5 years, ProPhase Labs' Net Income towards Common Stockholders (Quarterly) stood at $11.4 million in 2021, then plummeted by 121.42% to -$2.4 million in 2022, then tumbled by 241.61% to -$8.3 million in 2023, then spiked by 90.59% to -$786,000 in 2024, then tumbled by 321.64% to -$6.8 million in 2025.
  • Its last three reported values are -$6.8 million in Q3 2025, -$4.5 million for Q2 2025, and $8.7 million during Q1 2025.